🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety of intravitreal Zimura™ (complement factor C5 inhibito...
Status
Completed
Location
Retinal Research Institute
Start Date
2017-10-11
Trial ID
NCT03362190
Treatments Being Tested
The objectives of this study were to evaluate the safety and efficacy of Zi...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-15
Trial ID
NCT02686658
Treatments Being Tested
The objectives of this study are to evaluate the safety, tolerability, and ...
Status
Completed
Location
Ophthotech Corp
Start Date
2008-10-16
Trial ID
NCT00709527
Treatments Being Tested
The objectives of this study are to evaluate the safety and tolerability of...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-12
Trial ID
NCT02397954
Treatments Being Tested
To asses the safety of intravitreal Zimura™ (complement factor C5 inhibitor...
Status
Withdrawn
Location
Retina Consultants of Hawaii
Start Date
2018-11
Trial ID
NCT03374670
The objectives of this study was to evaluate the safety and efficacy of ava...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2020-06-22
Trial ID
NCT04435366
Treatments Being Tested
The primary objective is to assess the safety of intravitreal (IVT) Zimura®...
Status
Terminated
Location
Multiple Locations
Start Date
2016-10-20
Trial ID
NCT05571267
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of avacinc...
Status
Completed
Location
Retinal Research Institute
Start Date
2018-01-12
Trial ID
NCT03364153
Treatments Being Tested
The objectives of this study are to evaluate the safety and tolerability of...
Status
Completed
Location
Ophthotech
Start Date
2009-07-16
Trial ID
NCT00950638
Treatments Being Tested
The purpose of this study is to assess long-term safety of avacincaptad peg...
Status
Completed
Location
Retinal Diagnostic Center
Start Date
2022-09-26
Trial ID
NCT05536297
Treatments Being Tested